Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction

Autor: Oday Salman, Lei Zhao, Jordana B. Cohen, Marie Joe Dib, Joe David Azzo, Sushrima Gan, A. Mark Richards, Bianca Pourmussa, Rob Doughty, Ali Javaheri, Douglas L. Mann, Ernst Rietzschel, Manyun Zhao, Zhaoqing Wang, Christina Ebert, Vanessa van Empel, Karl Kammerhoff, Joseph Maranville, Joseph Gogain, Jaclyn Dennis, Peter H. Schafer, Dietmar Seiffert, David A. Gordon, Francisco Ramirez‐Valle, Thomas P. Cappola, Julio A. Chirinos

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 17 (2024)

Background Kidney disease is common in heart failure with preserved ejection fraction (HFpEF). However, the biologic correlates and prognostic significance of kidney injury (KI), in HFpEF, beyond the estimated glomerular filtration rate (eGFR), are u

Externí odkaz: https://doaj.org/article/005acfdc8a4844deafa49b506123ac19

Urinary Proteomics and Outcomes in Heart Failure With Preserved Ejection Fraction

Autor: Corinne Carland, Lei Zhao, Oday Salman, Jordana B. Cohen, Payman Zamani, Qing Xiao, Ashok Dongre, Zhaoqing Wang, Christina Ebert, Danielle Greenawalt, Vanessa van Empel, A. Mark Richards, Robert N. Doughty, Ernst Rietzschel, Ali Javaheri, Yixin Wang, Peter H. Schafer, Sarah Hersey, Leonidas N. Carayannopoulos, Dietmar Seiffert, Ching‐Pin Chang, David A. Gordon, Francisco Ramirez‐Valle, Douglas L. Mann, Thomas P. Cappola, Julio A. Chirinos

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)

Background Although several studies have addressed plasma proteomics in heart failure with preserved ejection fraction, limited data are available on the prognostic value of urinary proteomics. The objective of our study was to identify urinary prote

Externí odkaz: https://doaj.org/article/31d03371ea994940952d131d3a850e78

High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension

Autor: Rachid Tobal, Judith Potjewijd, Daan van Doorn, Vanessa van Empel, Jan Damoiseaux, Pieter van Paassen

Publikováno v: Diagnostics, Vol 14, Iss 14, p 1471 (2024)

Pulmonary hypertension (PH) is a serious condition linked to immune-system dysfunction. Myositis-specific/associated antibodies (MSAs/MAAs) play a role in idiopathic inflammatory myopathy (IIM) and interstitial lung disease (ILD), but their significa

Externí odkaz: https://doaj.org/article/0e57133955064d96bf3d1ca0e3cb2f8d

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis

Autor: Sharon Remmelzwaal, Adriana J. van Ballegooijen, Linda J. Schoonmade, Elisa Dal Canto, M. Louis Handoko, Michiel T. H. M. Henkens, Vanessa van Empel, Stephane R. B. Heymans, Joline W. J. Beulens

Publikováno v: BMC Medicine, Vol 18, Iss 1, Pp 1-14 (2020)

Abstract Background An overview of the diagnostic performance of natriuretic peptides (NPs) for the detection of diastolic dysfunction (DD) and heart failure with preserved ejection fraction (HFpEF), in a non-acute setting, is currently lacking. Meth

Externí odkaz: https://doaj.org/article/bec7f4f7cf1b4ec491b83b6b05691fdb

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II)

Autor: Sanjiv J Shah, Barry A Borlaug, Eugene S Chung, Donald E Cutlip, Philippe Debonnaire, Peter S Fail, Qi Gao, Gerd Hasenfuß, Rami Kahwash, David M Kaye, Sheldon E Litwin, Philipp Lurz, Joseph M Massaro, Rajeev C Mohan, Mark J Ricciardi, Scott D Solomon, Aaron L Sverdlov, Vijendra Swarup, Dirk J van Veldhuisen, Sebastian Winkler, Martin B Leon, Joseph Akar, Jiro Ando, Toshihisa Anzai, Masanori Asakura, Steven Bailey, Anupam Basuray, Fabrice Bauer, Martin Bergmann, John Blair, Jeffrey Cavendish, Eugene Chung, Maja Cikes, Ira Dauber, Erwan Donal, Jean-Christophe Eicher, Peter Fail, James Flaherty, Xavier Freixa, Sameer Gafoor, Zachary Gertz, Robert Gordon, Marco Guazzi, Cesar Guerrero-Miranda, Deepak Gupta, Finn Gustafsson, Cyrus Hadadi, Emad Hakemi, Louis Handoko, Moritz Hass, Jorg Hausleiter, Christopher Hayward, Gavin Hickey, Scott Hummel, Imad Hussain, Richard Isnard, Chisato Izumi, Guillaume Jondeau, Elizabeth Juneman, Koichiro Kinugawa, Robert Kipperman, Bartek Krakowiak, Selim Krim, Joshua Larned, Gregory Lewis, Erik Lipsic, Anthony Magalski, Sula Mazimba, Jeremy Mazurek, Michele McGrady, Scott Mckenzie, Shamir Mehta, John Mignone, Hakim Morsli, Ajith Nair, Thomas Noel, James Orford, Kishan Parikh, Tiffany Patterson, Martin Penicka, Mark Petrie, Burkert Pieske, Martijn Post, Philip Raake, Alicia Romero, John Ryan, Yoshihiko Saito, Takafumi Sakamoto, Yasushi Sakata, Michael Samara, Kumar Satya, Andrew Sindone, Randall Starling, Jean-Noël Trochu, Bharathi Upadhya, Jan van der Heyden, Vanessa van Empel, Amit Varma, Amanda Vest, Tobias Wengenmayer, Ralf Westenfeld, Dirk Westermann, Kazuhiro Yamamoto, Andreas Zirlik

Publikováno v: LANCET, 399(10330), 1130-1140. ELSEVIER SCIENCE INC
REDUCE LAP-HF II investigators 2022, ' Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II) : a randomised, multicentre, blinded, sham-controlled trial ', The Lancet, vol. 399, no. 10330, pp. 1130-1140 . https://doi.org/10.1016/S0140-6736(22)00016-2
The Lancet, 399(10330), 1130-1140. Elsevier Limited

Background Placement of an interatrial shunt device reduces pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction. We aimed to investigate whether an interatrial shunt can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a234b151fc7802938519888819ed3f8
https://research.rug.nl/en/publications/45900625-7796-416c-9dcb-916faecdcff6